Acquired sulfhemoglobinemia: An underreported diagnosis?

Western Journal of Medicine

Volumn 169, Issue 6, 1998, Pages 386-389

  Noor, Mustafa ^a   Beutler, Ernest ^b,c  

^a Div Grad Med Educ Gen Int Med   (United States)

^b SCRIPPS RESEARCH INSTITUTE   (United States)

^c Dept of Molec and Exp Medicine ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; COTRIMOXAZOLE; ESTROGEN; LISINOPRIL; NORFLOXACIN; PHENAZOPYRIDINE; PROGESTERONE; SIMVASTATIN; TRAZODONE;

AGED; ARTICLE; BLOOD GAS ANALYSIS; CASE REPORT; CLINICAL FEATURE; CYANOSIS; DIFFERENTIAL DIAGNOSIS; FEMALE; HEMATOLOGIC DISEASE; HEMOGLOBIN DETERMINATION; HUMAN; METHEMOGLOBINEMIA; URINARY TRACT INFECTION;

AGED; CYANOSIS; DIAGNOSIS, DIFFERENTIAL; FEMALE; HUMANS; METHEMOGLOBIN; METHEMOGLOBINEMIA; SULFHEMOGLOBIN; SULFHEMOGLOBINEMIA;

EID: 0032408590     PISSN: 00930415     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (16)

1. Finch CA. Methemoglobinemia and sulfhemoglobinemia. N Enal J Med 1948:239:470-478
2. Goodman L, Oilman A. The Pharmacologic Basis of Medical Therapeutics, 8th ed. New York, McGraw Hill. 1990, p 1047
3. Bass AD, Saulter WT. 2-Anilinocthanol - an industrial hazard. JAMA 1943; 123:761-763
4. Reynold TB, Ware AG. Sulfhemoglobinemia following habitual use of acetanilide. JAMA 1952; 149:1538-1541
5. Discombe G. Sulfhaemoglobinacmia and glutathione. Lancet 1960; ii:371-372
6. Park CM, Nagel RL. Sulfhemoalobinemia: clinical and molecular aspects. N Engl J Med 1984; 310:1579-1584
7. Cox WW, Wendel WB. Normal rate of reduction of net hemoglobin in doss. J Biol Chem 1942; 143:331-340
8. Hultquist DE. Methemoglobin reduction system for erythrocytes. In Fleischer S, Packer L (Eds): Methods in Enzymology, vol. 52. New York, Academic Press, 1978
9. Goluboff N, Wheaton R. Methylene blue-induced cyanosis and acute hemolytic anemia complicating the treatment of methemoglobinemia. J Pediatr 1961:58:86-89
10. Rosen PJ, Johnson C, McGehee WG, Beutler E. Failure of methylene blue treatment in toxic methemoglobinemia. Association with glucose-6-phosphate dehydrogenase deficiency. Ann Intern Med 1971; 75:83-86
11. Harvey JW, Keitt AS. Studies of the efficacy and potential hazards of methylene blue therapy in aniline-induced methacmoglobinaemia. Br J Haematol 1983; 54:29-41
12. IL482 Co-Oximeter System. Operator's manual, section 1.3. Lexington, Massachusetts, Instrumentation Laboratory
13. Zwart A, Buursma A, van Kampen EJ, Oeseburg B, van der Ploeg PH, Zijlstra WG. A multi-wavelength spectrophotometric method for the simultaneous determination of five haemoglobin derivatives. J clin Chem Clin Biochem 1981; 19:457-463
14. van Kampen EJ, Volger H, Zijlstra WG, et al. Spectrophotometric determination of carboxyhemoglobin in human blood and the application of this method to the estimation of carbonmonoxide in gas mixtures. Klonikl Ned Akad Wetenschap Proc 1951:57:320-331
15. Dijkhuzen P, Buursma A, Gerding AM, Zijlstra WG. Sulfhaemoglobin. Absorption spectrum, millimolar extinction coefficient at lambda = 620 nm, and interference with the determination of hemoglobin and of haemoglobin-cyanide. Clin Chim Acta 1977; 78:479-487
16. Beutler E. Carboxyhemoglobin, methemoglobin, and sulfhemoglobin determinations. In Beutler E, Lichtman MA, Coller BS, Kipps TJ (Eds): Hematology. New York, McGraw Hill, 1995, pp L50-L51